# FDA Inspection 1290798 - Neopharm Labs Inc. - September 12, 2025

Source: https://www.keypedia.com/records/fda_inspections/neopharm-labs-inc/4ef0f510-266a-4c8d-9ca0-8c2b0dbcae4d
Source feed: FDA_Inspections

> FDA Inspection 1290798 for Neopharm Labs Inc. on September 12, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1290798
- Company Name: Neopharm Labs Inc.
- Inspection Date: 2025-09-12
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1290798 - 2025-09-12](https://www.keypedia.com/records/fda_inspections/neopharm-labs-inc/8e394e21-9697-41c6-b259-04876ae9275e)
- [FDA Inspection 1290798 - 2025-09-12](https://www.keypedia.com/records/fda_inspections/neopharm-labs-inc/9ed1476c-73c4-4646-ae84-026f6edb06ac)
- [FDA Inspection 1290798 - 2025-09-12](https://www.keypedia.com/records/fda_inspections/neopharm-labs-inc/af9ff9c7-5a61-4598-ab3a-32965637f769)
- [FDA Inspection 1088026 - 2019-03-19](https://www.keypedia.com/records/fda_inspections/neopharm-labs-inc/141603b2-0081-4fc7-9a96-b48dffd45212)
- [FDA Inspection 1048559 - 2018-02-09](https://www.keypedia.com/records/fda_inspections/neopharm-labs-inc/8b1c976d-7ce6-4706-bd95-1ad9794a7337)

Company: https://www.keypedia.com/companies/neopharm-labs-inc/9c41bd0f-2664-4b07-829f-bb1a8fce0b3b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c